Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.780
+0.110 (4.12%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Employees
Serina Therapeutics had 16 employees as of December 31, 2025. The number of employees increased by 3 or 23.08% compared to the previous year.
Employees
16
Change (1Y)
3
Growth (1Y)
23.08%
Revenue / Employee
$8,125
Profits / Employee
-$1,347,375
Market Cap
41.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 3 | 23.08% | 16 | 0 |
| Dec 31, 2024 | 13 | 2 | 18.18% | 12 | 1 |
| Dec 31, 2023 | 11 | - | - | 9 | 2 |
| Sep 30, 2023 | 9 | - | - | 5 | 4 |
| Jun 30, 2023 | 9 | - | - | 5 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| BeyondSpring | 44 |
| Enlivex | 34 |
| Veru Inc. | 20 |
| Lantern Pharma | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Nutriband | 13 |
SER News
- 18 days ago - Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 19 days ago - Serina Therapeutics completes enrollment and dosing in Parkinson’s trial - TheFly
- 19 days ago - Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire
- 20 days ago - Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board - TheFly
- 20 days ago - Serina Therapeutics Appoints Farrell Simon to its Board of Directors - GlobeNewsWire
- 4 weeks ago - Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252 - TheFly
- 4 weeks ago - Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics initiated with a Buy at BTIG - TheFly